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GI-VII-6 is a chromosomally integrated multidrug resistance genomic island harbored
by a specific clone of Salmonella enterica serovar Typhimurium (S.Typhimurium). It
contains a gene encoding CMY-2 β-lactamase (blaCMY 2), and therefore contributes to−
extended-spectrum cephalosporin resistance. To elucidate the significance of GI-VII-6 on
adaptive evolution, spontaneous mutants of S. Typhimurium strain L-3553 were selected
on plates containing cefotaxime (CTX). The concentrations of CTX were higher than its
minimum inhibition concentration to the parent strain. The mutants appeared on the
plates containing 12.5 and 25mg/L CTX at a frequency of 10−6 and 10−8, respectively.
No colonies were observed at higher CTX concentrations. The copy number of blaCMY−2
increased up to 85 per genome in the mutants, while the parent strain contains one
copy of that in the chromosome. This elevation was accompanied by increased amount
of transcription. The blaCMY−2 copy number in the mutants drastically decreased in the
absence of antimicrobial selection pressure. Southern hybridization analysis and short-read
mapping indicated that the entire 125 kb GI-VII-6 or parts of it were tandemly amplified.
GI-VII-6 amplification occurred at its original position, although it also transposed to other
locations in the genome in some mutants, including an endogenous plasmid in some of
the mutants, leading to the amplification of GI-VII-6 at different loci. Insertion sequences
were observed at the junction of the amplified regions in the mutants, suggesting
their significant roles in the transposition and amplification. Plasmid copy number in the
selected mutants was 1.4 to 4.4 times higher than that of the parent strain. These data
suggest that transposition and amplification of the blaCMY−2-containing region, along with
the copy number variation of the plasmid, contributed to the extensive amplification of
blaCMY 2 and increased resistance to CTX.−
Keywords: resistance, genomic island, insertion sequence, gene duplication and amplification, Salmonella enterica
serovar Typhimurium
INTRODUCTION
Non-typhoidal Salmonella (NTS) infection causes enterocolitis
with diarrhea and/or invasive disease with bacteremia. Extended-
spectrum cephalosporins (ESCs) or fluoroquinolones are com-
monly used as a first-line agent for the treatment of NTS
infections, if susceptibilities to antimicrobials are unknown. In
particular, ESCs are preferred, because fluoroquinolones are not
recommended for use in children (Hohmann, 2001). Therefore,
emergence of ESC-resistant NTS poses a threat to public
health. Resistance to ESCs among Salmonella enterica serovars is
attributed to the acquisition of Ambler class A extended-spectrum
β-lactamases (ESBLs) and/or Ambler class C cephamycinases
(AmpC β-lactamases). Of these, CMY-2, an AmpC β-lactamase
encoded by the blaCMY−2 gene, is the most frequently detected
enzyme among NTS (Michael et al., 2006).
Human salmonellosis is mainly acquired by the ingestion of
animal products, including meat, milk, and eggs (Mead et al.,
1999). The use of antimicrobials in food-producing animals
selects for bacteria resistant to antimicrobials used in humans
(Phillips et al., 2004). We have continuously monitored the
antimicrobial resistance of S. enterica serovar Typhimurium (S.
Typhimurium) isolated from cattle in Japan (Tamada et al.,
2001). Since 2004, S. Typhimurium isolates that are resis-
tant to ESC have been detected in the northern major island,
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Hokkaido (Tamamura et al., 2011). Most of these ESC-resistant
S. Typhimurium isolates have been noted to harbor one copy
of blaCMY−2 in their chromosome as an element of a 125-
kb genomic island, GI-VII-6 (Figure 1). A large proportion
of GI-VII-6 (99%) shows a high sequence similarity (>99%)
with Escherichia coli plasmid, pAR060302 (size, 167 kb). Directly
repeated copies of insertion sequence IS26 were present at both
ends of GI-VII-6 (Shahada et al., 2011). Insertion sequences
are the simplest transposable elements and can induce trans-
position of flanking genes to other replicons with themselves
(Mahillon and Chandler, 1998). In fact, junction region of this
genomic island were flanked by an 8-bp direct repeat, suggest-
ing that GI-VII-6 was acquired by transposition involving IS26
transposase (Shahada et al., 2011). Minimum inhibitory concen-
trations (MICs) of oxyimino-cephalosporins against these isolates
have been found to be lower than those of other bacteria pro-
ducing plasmid-encoded CMY-2 β-lactamases or ESBLs (Bonnet,
2004; Jacoby, 2009; Shahada et al., 2011). The significance of GI-
VII-6 on ESC resistance and clonal spread of GI-VII-6 positive
isolates is not yet clear.
Gene duplication and amplification (GDA) is known to be an
important adaptive mechanism in both prokaryotes and eukary-
otes under the existence of selection pressures such as anitimi-
crobials and carbon starvation (Andersson and Hughes, 2009).
Bacterial genomic regions of up to 300 kb can be selected under
antimicrobial selection pressures with the copy numbers of up to
40 (Sandegren and Andersson, 2009). The amplified genes alter
the antimicrobial resistance phenotypes of the bacteria. For exam-
ple, resistance of bacteria to sulfonamides, trimethoprim, and
β-lactams can be increased by GDA of genes encoding antimi-
crobial hydrolytic enzymes, target enzymes, or efflux pumps
(Andersson and Hughes, 2009; Sandegren and Andersson, 2009).
Although the detailed mechanisms of GDA are still controver-
sial, direct repeats flanking a region can contribute successful
amplification (Sandegren and Andersson, 2009). The presence
of directly repeated copies of IS26 flanking GI-VII-6 (Shahada
et al., 2011) prompted us to investigate whether increased ESC
resistance due to GDA occurs in the S. Typhimurium iso-
lates harboring GI-VII-6. The purpose of the present study
is to understand the significance of GI-VII-6 in the adap-
tive evolution of S. Typhimurium under antimicrobial selection
pressure.
Thus, we selected and analyzed spontaneous mutants of an
S. Typhimurium strain harboring GI-VII-6 on cephalosporin-
containing plates. GI-VII-6 was extensively amplified in all of the
mutants by GDA mechanisms. However, the amplification pat-
tern was more complex than we initially predicted. Pre-existing
or transposed insertion sequences were observed at the junction
of the amplified regions. The importance of insertion sequences
on the adaptive evolution was highlighted in this study.
MATERIALS AND METHODS
SELECTION OF S. TYPHIMURIUMMUTANTS WITH INCREASED
RESISTANCE TO CEFOTAXIME
To select S. Typhimurium spontaneous mutants with increased
resistance to cefotaxime (CTX), L-3553 (Shahada et al., 2011)
harboring GI-VII-6 in the chromosome was used as the parent
strain. Whole-genome sequence of this strain was reported previ-
ously (Sekizuka et al., 2014). The MIC of CTX against this strain
was 8mg/L. This strain was inoculated into 3ml of Luria–Bertani
(LB) broth (Becton, Dickinson and Company, Franklin Lakes, NJ,
USA) and incubated at 37◦C and 150 rpm for 20 h. The shak-
ing speed employed for broth culture was the same throughout
this study. The culture was serially diluted and spread on LB agar
plates (Becton, Dickinson and Company) containing 12.5, 25, 50,
or 100mg/L CTX (Sigma-Aldrich Co. LLC., St. Louis, MO, USA).
In addition, the same culture was spread on LB agar plates with-
out antimicrobials. The frequency of the mutations was estimated
from the number of colonies on LB agar plates with CTX divided
by that on plates without CTX. Twenty colonies were picked from
the CTX-containing plates and inoculated into fresh LB broth
with CTX (at the same concentration to that used in the initial
selection) and incubated at 37◦C for 24 h under constant shak-
ing. Each culture was mixed with same volume of 50% (vol/vol)
glycerol and stored at -80◦C until further use.
DETERMINATION OF MIC
MIC was determined by the agar dilution method using Mueller–
Hinton agar (Becton, Dickenson and Company), according to
the procedure recommended by the Clinical and Laboratory
Standards Institute (2008). The following internal quality con-
trol strains were used: Staphylococcus aureus ATCC 29213,
Enterococcus faecalis ATCC 29212, E. coli ATCC 25922, and
Pseudomonas aeruginosa ATCC 27853. The antimicrobials tested
were as follows: CTX, ceftriaxone (CRO), ceftazidime (CAZ),
cefoxitin (FOX), streptomycin (STR) (Sigma-Aldrich Co. LLC.),
chloramphenicol (CHL) (Nacalai Tesque, Inc., Kyoto, Japan), and
oxytetracycline (OTC) (Wako Pure Chemical Industries, Ltd.,
Osaka, Japan).
FIGURE 1 | Schematic view of antimicrobial resistance regions located in GI-VII-6. Each arrow indicates gene according to the following scheme: blue,
genes for IS26 transposase; orange, resistance genes; gray, other genes. GI-VII-6 were flanked by an 8-bp direct repeat.
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EXTRACTION OF GENOMIC DNA
Genomic DNA was extracted from 1ml of 24-h culture using
Wizard Genomic DNA Purification Kit (Promega Corporation,
Madison, WI, USA), and used for quantitative real-time PCR
(qPCR), PCR, and short-read DNA sequencing.
qPCR
Primers used in this study for qPCR are listed in Table S1.
Oligonucleotides were purchased from Hokkaido System Science
Co., Ltd. (Sapporo, Japan). The qPCR technique was used for the
quantification of relative copy number of blaCMY−2. Each reac-
tion mixture contained 1X THUNDERBIRD SYBR qPCR Mix
(Toyobo Co., Ltd., Osaka, Japan), 0.1X ROX (Toyobo Co., Ltd.),
and 0.15μM of each primer. The thermal conditions were ini-
tial denaturation at 95◦C for 1min, followed by 30 cycles of 95◦C
for 15 s and 60◦C for 40 s. The signal was monitored using ABI
Prism 7500 Real-time PCR System (Life technologies, Carlsbad,
CA, USA). Standard curve method was used for relative quantifi-
cation of target genes (Peirson et al., 2003). The rpsJ and dnaN
genes were used as a single copy control in all experiments. The
copy number was generated from a ratio of the relative amount of
blaCMY−2 to that of a single copy gene. DNA of the parent strain,
L-3553, was used to normalize the blaCMY−2 copy number of the
mutants in every individual run.
PERIODICAL QUANTIFICATION OF blaCMY−2 COPY NUMBER AND
mRNA EXPRESSION
One hundred microliter of the frozen stock of each strain was
inoculated into 100ml of LB broth containing CTX and incu-
bated at 37◦C under constant shaking. The optical density at
600 nm (OD600) of each culture was measured and a portion
of the culture was collected for DNA and RNA extraction in
early logarithmic phase (OD600 = 0.5), middle logarithmic phase
(OD600 = 1.5), late logarithmic phase (OD600 = 2.5), early sta-
tionary phase (OD600 = 3.0), and late stationary phase (24 h).
The genomic DNA was extracted as described above and total
RNA was extracted using RNAprotect Bacteria Reagent and
RNeasy Mini Kit (Qiagen, Venlo, Netherlands). mRNA was con-
verted to cDNA using the PrimeScript RT reagent Kit (Takara Bio
Inc., Shiga, Japan) with random hexamers provided with the kit.
qPCR was performed as described earlier to determine the rela-
tive expression level of mRNA for blaCMY−2. The parent strain,
L-3553, was used to normalize the mRNA fold change. Because
our preliminary data suggested that the nrfG expression was sta-
ble throughout different growth stages (data not shown), it was
used as an internal control for mRNA quantification.
PCR AND DNA SEQUENCING
Primers used in this study for PCR are listed in Table S1. PCR
was performed using an iCycler apparatus (Bio-Rad Laboratories,
Hercules, CA, USA), and Takara Ex Taq (Takara Bio Inc.) was
used as the DNA polymerase for each PCR. The amplified frag-
ments were purified using the ExoSAP-IT (USB Corporation,
Cleveland, OH, USA), and the nucleotide sequence of both
strands was determined using an Applied Biosystems 3130xl
Genetic Analyzer with the BigDye Terminator cycle sequenc-
ing kit (version 3.1; Applied Biosystems, Foster City, CA, USA).
The sequences were then assembled with Sequencher version
4 (Hitachi Solutions, Kanagawa, Japan) and the DNA align-
ment was examined using the Basic Local Alignment Search Tool
(http://blast.ncbi.nlm.nih.gov/Blast.cgi).
SHORT-READ DNA SEQUENCING AND MAPPING ON GI-VII-6
SEQUENCE
DNA libraries (insert size: ∼600 bp) were prepared using the
Nextera XT DNA Sample Prep Kit (Illumina, San Diego, WI).
DNA cluster generation and paired-end sequencing run for 170
mers were performed using an Illumina MiSeq with the MiSeq
500 cycle Kit v2. The fluorescent images were analyzed using the
Illumina RTA1.17.22/MCS2.1.43 base-calling pipeline to obtain
FASTQ-formatted sequence data. To generate short-read map-
ping data of all strains compared to the chromosome and plasmid,
pST3553 of S. Typhimurium L-3553 [DNA Data Bank of Japan
(DDBJ) accession numbers AP014565 and AP014566, respec-
tively], BWA-SW (Li and Durbin, 2010), and SAMtools (Li et al.,
2009) software were used with the default parameters. The map-
ping data obtained were visualized with GenomeJack viewer
software (Mitsubishi Space Software, Tokyo, Japan), and themean
coverage, whichmeans average value of coverage of short reads on
a specific genomic region, was calculated using R software version
3.0.0 (R Core Team, 2013).
SOUTHERN HYBRIDIZATION ANALYSIS
To confirm the chromosomal location of blaCMY−2 and relevant
genes among the strains L-3553 and its derivatives, pulsed-field
gel electrophoresis (PFGE) followed by Southern hybridization
analysis were performed according to methods described previ-
ously (Shahada et al., 2011), with some modifications. In brief, a
plug of each strain was prepared using 24-h cultures. The plugs
were digested with 60U/ml of XbaI (Takara Bio Inc.) or 40U/ml
of FseI (New England BioLabs, Ipswich, MA, USA) at 37◦C for
6 h, or 2 U/ml of S1 nuclease (Takara Bio Inc.) at 37◦C for 45min.
Primers used for probe synthesis were listed in Table S1.
STATISTICAL ANALYSIS
Wilcoxon rank sum test was used to compare the blaCMY−2 copy
number between increased CTX resistance mutants selected from
the 12.5 and 25mg/L CTX-containing plates. R2-value between
the copy number of the genomic DNA and themRNA fold change
in blaCMY−2 in all strains tested was calculated. These analyses
were performed using R software version 3.0.0.
NUCLEOTIDE SEQUENCE ACCESSION NUMBERS
The sequence reads obtained from the S. Typhimurium strains
were deposited in DDBJ Sequence Read Archive under the acces-
sion number DRA001681.
RESULTS
FREQUENCY OF SELECTION AND COPY NUMBER OF blaCMY−2 GENE
IN SPONTANEOUS MUTANTS
Spontaneous mutants were selected on the plates containing 12.5
and 25mg/L CTX with a frequency of 1.1 × 10−6 ± 6.0 × 10−7
and 3.4 × 10−8 ± 1.6 × 10−8 (mean ± SD), respectively. No
colonies appeared on the plates containing 50 and 100mg/L CTX,
suggesting that the frequency was less than 1.2 × 10−10. Twenty
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colonies were picked from each of the plates containing 12.5 and
25mg/L CTX, and the copy number of blaCMY−2 was quantified.
In the preliminary experiments, we determined the blaCMY−2
copy number of selected strains for three times and calculated
the coefficient of variation (CV = standard deviation divided by
mean). CV for the biological replicate was 0.153, whereas that
for the technical replicate was 0.102. As shown in Table 1, all the
mutants harbored multiple blaCMY−2 copies, ranging from 5.9 to
85.3, while the average blaCMY−2 copy number in 10 colonies of
L-3553 on the LB agar plate was 1.01 ± 0.06. Higher variance in
Table 1 | Copy numbers of blaCMY−2 and MICs of various antimicrobials for S. Typhimurium L-3553 and the spontaneous mutants selected on
CTX-containing plates.
Strain CTX concentration blaCMY-2 MIC (mg/L)a Approx. size of
for selection (mg/L) copy no. plasmid (kb)b
CTX CRO CAZ FOX CHL STR OTC
L-3553 Not applicable 1.0 8 8 32 16 64 256 128 130
12-1 12.5 16.5 64 128 256 128 256 512 128 130
12-2 12.5 16.5 32 128 256 128 256 512 128 130
12-3 12.5 16.8 32 64 256 128 256 512 128 130
12-4 12.5 15.3 32 128 256 128 256 512 128 130
12-5 12.5 13.8 64 64 256 128 256 >512 128 130
12-6 12.5 15.8 32 128 256 128 256 >512 128 130
12-7 12.5 15.5 32 128 256 128 256 512 128 130
12-8 12.5 15.7 64 128 256 128 256 >512 128 130
12-9 12.5 17.4 64 64 256 128 256 >512 128 130
12-10 12.5 15.9 32 64 128 128 256 512 128 130
12-11 12.5 25.7 64 64 256 128 256 512 128 255, 390, 510, 640
12-12 12.5 24.5 64 128 256 128 256 512 128 255, 390, 510, 640
12-13 12.5 18.5 64 128 256 128 256 512 128 255, 390, 510, 640
12-14 12.5 25.7 64 128 256 128 256 512 128 255, 390, 510, 640
12-15 12.5 7.1 64 128 256 128 128 256 128 130, 255
12-16 12.5 14.9 32 64 256 128 256 512 128 130
12-17 12.5 21.7 64 128 256 128 256 512 128 255, 390, 510, 640
12-18 12.5 21.8 64 128 256 128 256 512 128 255, 390, 510, 640
12-19 12.5 5.9 64 128 256 128 256 512 128 130
12-20 12.5 17.3 32 64 256 128 256 >512 128 130
25-4 25 11.1 128 256 >512 128 256 >512 128 320, 430
25-5 25 15.4 128 256 >512 512 256 >512 256 130
25-6 25 85.3 64 128 512 256 256 512 128 510
25-7 25 17.1 128 256 >512 512 256 >512 256 130
25-8 25 67.4 64 128 512 256 256 512 128 440
25-9 25 18.8 128 256 >512 256 256 >512 256 130
25-10 25 12.9 128 256 512 256 256 >512 256 130
25-11 25 9.0 128 256 512 512 64 128 256 130
25-12 25 12.1 128 256 >512 512 256 >512 256 130
25-13 25 12.0 128 256 512 256 256 >512 128 130
25-14 25 15.9 64 128 512 128 256 >512 128 130
25-15 25 44.8 128 256 512 512 256 512 256 320, 390, 475, 560
25-16 25 13.1 128 256 >512 512 64 >512 128 130, 340, 440
25-17 25 34.1 128 128 512 128 256 >512 128 185, 250, 375, 495, 620
25-18 25 9.3 128 128 512 256 256 >512 256 130, 640
25-19 25 13.6 128 128 512 256 256 >512 128 130, 640
25-20 25 33.2 128 256 >512 512 256 >512 256 510, 570, 640
25-21 25 12.7 128 256 >512 256 256 >512 128 130
25-22 25 33.4 128 256 512 256 256 256 128 390, 475, 560, 640
25-23 25 12.8 128 256 >512 512 256 >512 128 130, 640
aCTX, cefotaxime; CRO, ceftriaxone; CAZ, ceftazidime; FOX, cefoxitin; CHL, chloramphenicol; STR, streptomycin; OTC, oxytetracycline.
bPlasmid size was estimated by PFGE after S1 nuclease digestion.
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copy numbers was observed in mutants selected at 25mg/L CTX
(9.0–85.3) than in mutants selected at 12.5mg/L CTX (5.9–25.7).
Moreover, the average copy number in the mutants selected from
plates containing 25mg/L CTX (24.2± 20.6) was higher than that
from plates containing 12.5mg/L CTX (17.1 ± 5.1), although the
difference was not statistically significant (p = 0.62).
MICs OF RELEVANT ANTIMICROBIALS AGAINST THE MUTANTS
To confirm the phenotypic changes of the mutants, we deter-
mined the MICs of six additional antimicrobials whose resistance
genes were located in GI-VII-6: resistance to CRO, CAZ, and FOX
is conferred by blaCMY−2, CHL resistance is conferred by floR,
STR resistance is conferred by aadA2, strA, and strB, and OTC
resistance is conferred by tetA (Figure 1). As shown in Table 1,
the MICs of CTX, CRO, and FOX were found to increase by
four- to 32-fold. The MIC of CAZ against some of the mutants
was over the detection limit. MIC50 and MIC90 of cephalosporin
antimicrobials against the mutants selected from plates contain-
ing 25mg/L CTX were higher than those from plates containing
12.5mg/L CTX (Table S2). The MIC of chloramphenicol against
the mutants increased four-fold, except for two strains showing
the same value as that of the parent strain, whereas MIC of strep-
tomycin against the mutants increased more than two-fold, but
the values were over the detection limit in half of the strains. MIC
of oxytetracycline against the mutants was comparable to that of
the parent strain.
PERIODICAL QUANTIFICATION OF blaCMY−2 COPY NUMBER AND
mRNA EXPRESSION
blaCMY−2 copy number in the genomic DNA and fold change
of mRNA were measured to confirm the correlation between
them. As shown in Figure 2, the copy number of blaCMY−2
increased rapidly in the early logarithmic phase, and then gradu-
ally increased from late logarithmic to stationary phase in strains
12-1, 12-19, and 25-11. In contrast, the copy number increased
linearly even in the stationary phase in strains 12-14, 25-6, and
25-17, leading to higher copy numbers. Furthermore, the fold
changes of mRNAwere significantly correlated with the blaCMY−2
copy numbers (R2 = 0.97, p < 10−5).
EFFECT OF SERIAL SUBCULTURE WITHOUT CTX ON blaCMY−2 COPY
NUMBERS
To check the stability of the amplified regions in the absence of
selection pressure, the six selected mutants were serially subcul-
tured in LB broth without CTX for ten times (100 generations).
As shown in Figure 3, the blaCMY−2 copy numbers drastically
decreased in all isolates. Strain 25-6 showed approximately 80%
decrease in the copy number in the first subculture. Subsequently,
the copy number continuously decreased during the serial sub-
culture, and finally reached a value of 3.0. The copy numbers of
the other five strains ranged from 0.8 to 2.9 at 100 generations.
IDENTIFICATION OF MUTATIONS BY SHORT-READ MAPPING
In the six selected mutants, no mutations were found in
blaCMY−2, or its promoter region. Furthermore, no point
mutations were observed among the mutants’ whole-genome
sequences, except for three non-synonymous mutations listed in
Table S4. We observed a 51-kb deletion [nucleotide (nt) posi-
tion 1763615–1814713] of chromosomal DNA in strain 25-17,
although the XbaI and FseI restriction sites were not affected by
these mutations.
LOCALIZATION OF blaCMY−2 BY SOUTHERN HYBRIDIZATION
ANALYSIS
The parent strain, L-3553, harbors a 133-kb plasmid, pST3553,
which is a derivative of S. Typhimurium specific virulence plas-
mid and does not contain blaCMY−2 gene (Sekizuka et al., 2014).
In some of the mutants, one or multiple plasmids with sizes larger
than the original were observed. Estimation by S1 nuclease-PFGE
indicated that the size of the plasmids varied from 255 to 660 kb
(Table 1). Southern hybridization analysis revealed that blaCMY−2
and the virulence plasmid specific gene, spvB, were both present
in the larger plasmids. In all strains tested, blaCMY−2 signal was
also present in the largest band, which is originated from the
chromosome (Figure 4A). spvB signals in the largest band seemed
a non-specific one, because we observed the signal even in the
parent strain L-3553.
To demonstrate the amplification of blaCMY−2 at the original
chromosomal position, we performed additional PFGE–Southern
hybridization analyses with a blaCMY−2 probe using FseI-digested
genomic DNA of the six selected mutants. As GI-VII-6 does not
contain an FseI site, it was located in its entirety in a 350-kb
band in L-3553 (Figures 4B,D). This band was not present in
the genomic DNA extracted from the mutants. A blaCMY−2 probe
was found to hybridize with the largest band originating from the
chromosome in the selected mutants. Additional blaCMY−2 sig-
nals originating from enlarged plasmids were observed in strains
12-14, 25-6, and 25-17. As the endogenous pST3553 plasmid
contains one FseI site, the sizes of the blaCMY−2-positive bands
corresponded to those of the enlarged plasmids.
Because GI-VII-6 contains one XbaI site (nt 1037120–
1037125) (Shahada et al., 2011), tandemly arrayed GI-VII-6
sequences should generate multiple copies of a specific sized frag-
ment after XbaI digestion (Figure 4D). As shown in Figure 4C,
we observed several bands of different sizes, which were not
found in the parent strain, after separation of XbaI-digested
genomic DNA of the selected mutants by PFGE. Most of them
were approximately 30–125 kb in size and showed higher fluo-
rescence intensity compared to the other bands. In subsequent
Southern hybridization analysis, blaCMY−2 signal was observed
in these bands. The sizes of the bands that showed the promi-
nent blaCMY−2 signal were approximately 100, 125, 100, 30, 80,
and 110 kb in strains 12-1, 12-14, 12-19, 25-6, 25-11, and 25-
17, respectively. In strain 25-6, additional weaker signals were
observed in the bands of approximately 40 and 85 kb in size. An
additional weaker signal was also observed in a 180-kb band in
strain 25-17.
ESTIMATION OF PLASMID COPY NUMBER BY SHORT-READ MAPPING
To estimate the plasmid copy number in the parent and each
mutant, the mean coverage of the pST3553 plasmid was divided
by that of the chromosome. The plasmid copy numbers of strains
L-3553, 12-1, 12-14, 12-19, 25-6, 25-11, and 25-17 were estimated
as 1.6, 2.3, 5.2, 2.7, 4.7, 1.9, and 7.1, respectively. Three strains
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FIGURE 2 | Time courses of bacterial growth and blaCMY−2 gene amplification in the six selected mutants. Bacterial growth is shown as OD600. The
copy number of gene and fold change of mRNA are indicated. Note that the y-axis for strain 25-6 is different from that for the others.
with a blaCMY−2 copy number greater than 25 (12-14, 25-6, and
25-17) showed higher plasmid copy numbers.
IDENTIFICATION OF THE AMPLIFIED REGION BY SHORT-READ
MAPPING
The results of the short-read mapping showed that the mean cov-
erage of the chromosomal genes (background) in the six selected
mutants ranged from 20.7 to 61.1 (Table S3). In this study, regions
showing a mean coverage that is greater than five times higher
than the background were regarded as amplified regions. As
shown in Figure 5, coverage of the entire or a part of GI-VII-6 was
higher than other regions in the six selected mutants. The ampli-
fied regions of strains 12-1, 12-14, and 12-19 were flanked by
directly repeated copies of IS26. The end points of the amplified
regions in strains 12-1 and 12-19 were the first and third copies of
IS26 (nt positions 983123–983942 and 1082604–1083423, respec-
tively) from the 5′-end of GI-VII-6. The size of the amplified
regions was 100 kb. In strain 12-14, the end point of the amplified
region was the first and fourth (nt position 1107425–1108244)
copies of IS26.
In contrast, we could not identify directly repeated sequences
at the ends of the amplified regions in strains 25-6, 25-11, and
25-17. The amplified regions in strain 25-6 started from an
intergenic region between STL3553_c09800 and STL3553_c09810
(nt position 1021052) and terminated at an intergenic region
between STL3553_c10000 and STL3553_c10010 (nt position
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FIGURE 3 | The blaCMY−2 copy number reduction in the six selected
mutants in the course of serial subculture without antimicrobials.
1048473). The mean coverage of this amplified region was 1296.9.
Furthermore, in this strain, the mean coverage from downstream
of the amplified region to nt position 1063378, located in the
middle of gene STL3553_c10130, was 231.1, which subsequently
decreased to 102.5 until just before the fourth copy of IS26. These
data suggest the existence of three different amplified regions [nt
positions 1021052–1048473 (27 kb), 1021052–1063378 (42 kb),
and 1021052–1108244 (87 kb)] sharing a portion of GI-VII-6
sequence. In strain 25-11, the 5′-end of the amplified region
started from 21 kb upstream of the 5′-end of GI-VII-6 (nt posi-
tion 962959) and terminated at the middle of ISEcp1 (nt position
1042417) within GI-VII-6, which accounted for a size of 80 kb.
The coverage dropped sharply in the middle of ISEcp1, while
it was still higher by several times than the background until
the 5′-end of the ISEcp1 inverted repeat (nt position 1043519)
(Figure S1). In strain 25-17, high mean coverage of 1269.7 was
observed from an intergenic region between STL3553_c09480
and STL3553_c09490 (nt position 984235) to the 3′-end of IS1294
(nt position 1096148), which accounted for a size of 112 kb.
(Figure S1). The sizes of these amplified regions in each mutant
corresponded to those of the bands that showed the prominent or
weaker blaCMY−2 signals (Figure 4C). Among the blaCMY−2 sig-
nals observed in Figure 4C, the origin of the 180-kb signal was
not identified in this study.
DNA SEQUENCE OF THE JUNCTION REGION
To determine the DNA sequence of the junction of the ampli-
fied region, we performed DNA sequencing of the PCR products.
Location of each primer to amplify the junction region of strains
12-1, 12-14, 12-19, 25-6, and 25-11 is indicated in Figure S2. In
strains 12-1, 12-14, and 12-19, the location of IS26 at the junc-
tion was confirmed. In addition, we confirmed the location of
IS26 at the junctions of three different amplified regions in strain
25-6. The location of IS1 at the junction of amplified region was
also confirmed in strain 25-11 (see Figure S3). We could not
successfully amplify the junction region in strain 25-17.
DISCUSSION
The present study demonstrates that increased cephalosporin
resistance of S. Typhimurium harboring GI-VII-6 under CTX
selection pressure is mainly based on the increased copy number
of blaCMY−2 gene by GDA mechanisms. This conclusion is
elicited from the following evidence. First, the mean coverage
of the entire or a part of GI-VII-6 was greater than five times
higher than that of other chromosomal regions (Table S3).
Second, blaCMY−2-positive fragments that were 30–125 kb in
size were observed after XbaI digestion of the genomic DNA
(Figure 4C), suggesting a tandem array of the amplified regions.
In addition, a blaCMY−2-positive chromosomal fragment of
350 kb in size was lost and a fragment of larger size appeared after
FseI digestion by Southern hybridization analysis (Figure 4B),
indicating that amplification occurred at the original position.
Third, increased copy number of blaCMY−2 was accompanied
by increased amount of transcription (Figure 2). Fourth, the
blaCMY−2 copy number drastically decreased in the course of
serial subculture without selection pressure (Figure 3). Lastly, the
frequency of the spontaneous-mutants selection was 10−6 and
10−8 on 12.5 and 25mg/L CTX-containing plates, respectively.
These frequencies are similar to those reported in previous GDA
studies and appear to be higher than those of point mutations.
Above-mentioned characteristics are in concordance with those
of GDA mechanisms reported previously (Andersson and
Hughes, 2009; Sandegren and Andersson, 2009).
Two major mechanisms have been proposed that can increase
gene copy number. One is the homologous and/or non-
homologous recombination based replication and the other
is rolling circle replication (Andersson and Hughes, 2009;
Sandegren and Andersson, 2009). The initial step of the former
mechanism is duplication either through non-equal homolo-
gous recombination between directly oriented repeats or through
RecA-independent mechanisms between short- or no-homology
regions. Following duplication, higher level amplification can
occur as a result of RecA-dependent recombination between the
tandem repeats generated by the initial duplication. Alternatively,
no duplication intermediates are required in the rolling circle
replication; a double-strand break allows single-strand invasion at
a homologous or micro-homologous region, followed by ampli-
fication. Compared to non-equal homologous recombination,
rolling circle replication can generate a large tandem array in a
single generation (Sandegren and Andersson, 2009).
In the present study, the amplified regions in the three mutants
selected on 12.5mg/L CTX-containing plates had directly ori-
ented IS26 copies at both ends (Figure 5). The initial duplication
appeared to have occurred between pre-existing IS26 copies in
these strains. In contrast, we could not find any homologous
sequences at both ends of the amplified regions in the remain-
ing three strains selected on 25mg/L CTX-containing plates by
short-read mapping. However, results of our PCR and sequenc-
ing analyses suggested that IS26 was found at the junctions of
the three different amplified regions in strain 25-6. Also, IS1 was
found at the junction of the amplified region in strain 25-11
(Figure S3). The IS26 and/or IS1 insertions at both ends of the
amplified regions may have preceded the amplification in these
mutants. In strain 25-6, we observed three prominent blaCMY−2
signals in Xba I-restricted fragments less than 100 kb in size
(Figure 4C), suggesting these regions were amplified at differ-
ent loci in the genome. Transposition of the blaCMY−2-containing
region flanked by directly repeated IS26 copies may have preceded
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FIGURE 4 | PFGE–Southern hybridization images demonstrating
blaCMY−2 and spvB locations in S. Typhimurium strains. (A) PFGE
separation of S1 nuclease-digested genomic DNA from the selected strains
followed by Southern hybridization with probes specific to blaCMY−2 and
spvB. An arrow indicates the position of the endogenous 133-kb plasmid, in
which the spvB signal was detected. Open triangles indicate the positions of
enlarged plasmids, in which both blaCMY−2 and spvB signals were detected.
Both signals were observed in multiple plasmid bands in strains 12-13, 12-14,
and 12-18. (B) PFGE separation of FseI-digested genomic DNA from the
selected strains followed by Southern hybridization with a blaCMY−2 probe.
An arrow indicates the original position of the restricted fragment (350 kb) in
which the chromosomal blaCMY−2 signal was detected. In the selected
mutants, this fragment was not present and the blaCMY−2 signal was
identified on the largest band as indicated by a closed trangle. Open triangles
indicate the position of enlarged plasmid observed in strains 12-14, 25-6, and
25-17. (C) PFGE separation of XbaI-digested genomic DNA from the selected
strains followed by Southern hybridization with a blaCMY−2 probe. An arrow
indicates the original position of the restricted fragment (520 kb) in which
chromosomal blaCMY−2 signal was detected. Closed triangles indicate the
position of blaCMY−2 signals that originated from tandemly amplified GI-VII-6.
(D) Restriction maps of the GI-VII-6 and its flanking region in the parent strain
L-3553 and the mutants with putative amplifications. One putative amplified
region presented is flanked by the first and the third copies of IS26 (upper),
and the other is flanked by the first and the fourth copies of IS26 (lower).
These amplified regions generate 100-kb (upper) and 125-kb (lower)
fragments after XbaI digestion, respectively.
the amplification in this mutant. This signifies that the amplifica-
tion site is not exclusively in the original position. Because the
parent strain contains four copies each of the IS26 and IS1 trans-
posases (Sekizuka et al., 2014), these insertion sequences may
transpose in the parent strain with a relatively high frequency.
Reams et al. (2012) reported that 97% of duplication events
resulted from recombination between IS3 among non-selectively
trapped 1800 spontaneous lac duplications, and that the forma-
tion of the duplications was stimulated by IS3 transposase and
plasmid transfer functions (TraI). As GI-VII-6 contains traI, the
multiple copies of IS26, IS1, and traI may increase the duplication
frequency mediated by IS26 and IS1.
S. Typhimurium L-3553 harbors a 133-kb virulence and
antimicrobial resistance plasmid, pST3553. We observed several
plasmids larger than pST3553 in part of the spontaneousmutants.
For example, the same set of four differently sized plasmids were
detected in strains 12-11, 12-12, 12-13, 12-14, 12-17, and 12-
18 by PFGE after S1 nuclease digestion with a size interval of
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FIGURE 5 | Coverage of short-reads obtained from S. Typhimurium
L-3553 and the six mutants (DDBJ Sequence Read Archive;
accession number DRA001681) on the GI-VII-6 sequence of strain
L-3553 (DDBJ accession number AP014565). In each row, the y-axis
shows the coverage of the short-reads. The ruler at the bottom
indicates the nucleotide number in the chromosome of strain L-3553.
The XbaI restriction site is indicated by a slim arrow. The gray
rectangle indicates the location of GI-VII-6. The colored arrows indicate
the location of key genes as explained in the open rectangle. The
locations of IS26 are indicated by pink vertical bands. Short reads
originated from IS26 are mapped to one of four copies of IS26 in
GI-VII-6 randomly.
120–135 kb. We observed both blaCMY−2 and spvB signals in
most plasmids (Figure 2), suggesting that these plasmids were
cointegrates of the endogenous plasmids with different copies of
GI-VII-6.We obtained E. coli transformant harboring the plasmid
from strain 12-18. Results of PCR scanning to check the structure
of GI-VII-6 (Shahada et al., 2011) revealed that the enlarged plas-
mid contained the entire GI-VII-6 sequence (data not shown).We
thus concluded that the enlarged plasmids were generated by the
transposition of GI-VII-6 into pST3553. The size of the plasmid is
38 times smaller than that of the chromosome. However, pST3553
shares several homologous regions with GI-VII-6 (Sekizuka et al.,
2014). The regions would increase the frequency of integration of
the GI-VII-6 into the plasmid mediated by homologous recombi-
nation. In addition, the plasmid copy number in the six selected
strains was 1.4 to 4.4 times higher than that of the parent strain.
Especially, strains with higher copy numbers of blaCMY−2 (12-
14, 25-6, and 25-17) harbored enlarged plasmids and expressed
higher copy numbers of plasmid. With the exception of the three
non-synonymous mutations (Table S4), we could not detect any
mutations among the genomic DNA of the selected mutants.
Thus, these results may be due to the copy-number variation
of the plasmid and selection of cells with higher copy-number
of the plasmid under the selection pressure. These data suggest
that transposition and amplification of the blaCMY−2-containing
region, along with the copy number variation of the enlarged
plasmid, contributed to the extensive amplification of blaCMY−2.
We showed that spontaneous mutants can be selected at
CTX concentration marginally above the MIC. No mutants were
detected on 50 and 100 mg/L CTX-containing plates, suggesting
that GDA is amenable to the mutant selection window (MSW)
theory (Drlica and Zhao, 2007). The MSW theory postulates that
antimicrobial-resistant mutant subpopulations present before the
initiation of antimicrobial treatment are enriched and amplified
during the therapy when the antimicrobial concentrations remain
in a specific range, the MSW. The upper boundary of the MSW
is the minimum concentration that can inhibit the growth of
all types of single mutants, called mutant prevention concentra-
tion (MPC). As duplication of any specific bacterial gene occurs
at a high rate (10−3–10−5/cell/division) (Anderson and Roth,
1981; Reams et al., 2010), overnight culture of the parent strain
should comprise a certain number of mutants with duplications
mediated by IS26 or IS1. These mutants may be enriched in the
presence of CTX after amplification of the blaCMY−2-containing
region with directly repeated copies of IS26 or IS1 at both ends.
Although effective amplification may contribute to resistance
against higher concentrations of CTX, there must be a limit, i.e.,
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an increase in the genome poses a fitness cost to the host (Nilsson
et al., 2006; Reams et al., 2010). In fact, we observed a drastic
reduction in the blaCMY−2 copy number in the course of serial
subculture without selection pressure.
Taken together, we conclude that GI-VII-6 amplification
occurred at the original position, while it also transposed to other
genomic locations, including an endogenous plasmid in some of
the mutants. Insertion sequences played important roles in the
transposition and amplification of blaCMY−2 containing regions.
The copy-number variation in the blaCMY−2-positive plasmid
partially contributed to the extensive amplification of blaCMY−2
in some of the mutants. In addition, the selection frequency of
mutants with gene amplification was higher than that of typi-
cal mutations, suggesting that gene amplification is one of the
adaptive mechanisms that occur prior to acquiring additional
mutations in order to facilitate antimicrobial resistance.
ACKNOWLEDGMENTS
This work was supported by the Japan Society for the Promotion
of Science, a Grant-in-Aid for Scientific Research (C), 2013–2015
(25460553).
SUPPLEMENTARY MATERIAL
The Supplementary Material for this article can be found online
at: http://www.frontiersin.org/journal/10.3389/fmicb.2015.
00078/abstract
REFERENCES
Anderson, P., and Roth, J. (1981). Spontaneous tandem genetic duplica-
tions in Salmonella typhimurium arise by unequal recombination between
rRNA (rrn) cistrons. Proc. Natl. Acad. Sci. U.S.A. 78, 3113–3117. doi:
10.1073/pnas.78.5.3113
Andersson, D. I., and Hughes, D. (2009). Gene amplification and adaptive evolu-
tion in bacteria. Annu. Rev. Genet. 43, 167–195. doi: 10.1146/annurev-genet-
102108-134805
Bonnet, R. (2004). Growing group of extended-spectrum β-lactamases: the CTX-
M enzymes. Antimicrob. Agents Chemother. 48, 1–14. doi: 10.1128/AAC.48.1.1-
14.2004
Clinical and Laboratory Standards Institute. (2008). Performance Standards for
Antimicrobial Disk and Dilution Susceptibility Test for Bacteria Isolated from
Animals, 3rd Edn., Approved Standard M31-A3. Wayne, PA: Clinical and
Laboratory Standards Institute.
Drlica, K., and Zhao, X. L. (2007). Mutant selection window hypothesis updated.
Clin. Infect. Dis. 44, 681–688. doi: 10.1086/511642
Hohmann, E. L. (2001). Nontyphoidal salmonellosis. Clin. Infect. Dis. 32, 263–269.
doi: 10.1086/318457
Jacoby, G. A. (2009). AmpC β-lactamases. Clin. Microbiol. Rev. 22, 161–182. doi:
10.1128/CMR.00036-08
Li, H., and Durbin, R. (2010). Fast and accurate long-read alignment with
Burrows-Wheeler transform. Bioinformatics 26, 589–595. doi: 10.1093/bioinfor-
matics/btp698
Li, H., Handsaker, B., Wysoker, A., Fennell, T., Ruan, J., Homer, N., et al.
(2009). The Sequence Alignment/Map format and SAMtools. Bioinformatics 25,
2078–2079. doi: 10.1093/bioinformatics/btp352
Mahillon, J., and Chandler, M. (1998). Insertion sequences. Microbiol. Mol. Biol.
Rev. 62, 725–774.
Mead, P. S., Slutsker, L., Griffin, P. M., and Tauxe, R. V. (1999). Food-related ill-
ness and death in the United States reply to Dr. Hedberg. Emerg. Infect. Dis. 5,
841–842. doi: 10.3201/eid0506.990625
Michael, G. B., Butaye, P., Cloeckaert, A., and Schwarz, S. (2006). Genes
and mutations conferring antimicrobial resistance in Salmonella: an
update. Microbes Infect. 8, 1898–1914. doi: 10.1016/j.micinf.2005.
12.019
Nilsson, A. I., Zorzet, A., Kanth, A., Dahlstrom, S., Berg, O. G., and Andersson,
D. I. (2006). Reducing the fitness cost of antibiotic resistance by amplifica-
tion of initiator tRNA genes. Proc. Natl. Acad. Sci. U.S.A. 103, 6976–6981. doi:
10.1073/pnas.0602171103
Peirson, S. N., Butler, J. N., and Foster, R. G. (2003). Experimental validation of
novel and conventional approaches to quantitative real-time PCR data analysis.
Nucleic Acids Res. 31:e73. doi: 10.1093/nar/gng073 doi: 10.1093/nar/gng073
Phillips, I., Casewell, M., Cox, T., De Groot, B., Friis, C., Jones, R., et al. (2004).
Does the use of antibiotics in food animals pose a risk to human health? A
critical review of published data. J. Antimicrob. Chemother. 53, 28–52. doi:
10.1093/jac/dkg483
R Core Team. (2013). R: A Language and Environment for Statistical Computing.
Vienna: R Foundation for Statistical Computing. Available online at: http://
www.r-project.org/
Reams, A. B., Kofoid, E., Kugelberg, E., and Roth, J. R. (2012). Multiple pathways of
duplication formation with and without recombination (RecA) in Salmonella
enterica. Genetics 192, 397–415. doi: 10.1534/genetics.112.142570
Reams, A. B., Kofoid, E., Savageau, M., and Roth, J. R. (2010). Duplication fre-
quency in a population of Salmonella enterica rapidly approaches steady state
with or without recombination. Genetics 184, 1077–1094. doi: 10.1534/genet-
ics.109.111963
Sandegren, L., and Andersson, D. I. (2009). Bacterial gene amplification: implica-
tions for the evolution of antibiotic resistance. Nat. Rev. Microbiol. 7, 578–588.
doi: 10.1038/nrmicro2174
Sekizuka, T., Lee, K., Kuroda, M., Kusumoto, M., Iwata, T., Uchida, I., et al.
(2014). Whole genome sequence of CMY-2 β-lactamase-producing Salmonella
enterica serovar Typhimurium strain L-3553. Genome Announc. 2, 4. doi:
10.1128/genomeA.00711-14
Shahada, F., Sekizuka, T., Kuroda, M., Kusumoto, M., Ohishi, D., Matsumoto, A.,
et al. (2011). Characterization of Salmonella enterica serovar Typhimurium iso-
lates harboring a chromosomally encoded CMY-2 β-lactamase gene located
on a multidrug resistance genomic island. Antimicrob. Agents Chemother. 55,
4114–4121. doi: 10.1128/AAC.00560-11
Tamada, Y., Nakaoka, Y., Nishimori, K., Doi, A., Kumaki, T., Uemura, N., et al.
(2001). Molecular typing and epidemiological study of Salmonella enterica
serotype Typhimurium isolates from cattle by fluorescent amplified-fragment
length polymorphism fingerprinting and pulsed-field gel electrophoresis.
J. Clin. Microbiol. 39, 1057–1066. doi: 10.1128/JCM.39.3.1057-1066.2001
Tamamura, Y., Uchida, I., Tanaka, K., Okazaki, H., Tezuka, S., Hanyu, H., et al.
(2011). Molecular epidemiology of Salmonella enterica serovar Typhimurium
isolates from cattle in Hokkaido, Japan: evidence of clonal replacement and
characterization of the disseminated clone. Appl. Environ. Microbiol. 77,
1739–1750. doi: 10.1128/AEM.01910-10
Conflict of Interest Statement: The authors declare that the research was con-
ducted in the absence of any commercial or financial relationships that could be
construed as a potential conflict of interest.
Received: 29 October 2014; accepted: 21 January 2015; published online: 10 February
2015.
Citation: Lee K, Kusumoto M, Sekizuka T, Kuroda M, Uchida I, Iwata T, Okamoto
S, Yabe K, Inaoka T and Akiba M (2015) Extensive amplification of GI-VII-6, a
multidrug resistance genomic island of Salmonella enterica serovar Typhimurium,
increases resistance to extended-spectrum cephalosporins. Front. Microbiol. 6:78. doi:
10.3389/fmicb.2015.00078
This article was submitted to Antimicrobials, Resistance and Chemotherapy, a section
of the journal Frontiers in Microbiology.
Copyright © 2015 Lee, Kusumoto, Sekizuka, Kuroda, Uchida, Iwata, Okamoto, Yabe,
Inaoka and Akiba. This is an open-access article distributed under the terms of the
Creative Commons Attribution License (CC BY). The use, distribution or reproduction
in other forums is permitted, provided the original author(s) or licensor are credited
and that the original publication in this journal is cited, in accordance with accepted
academic practice. No use, distribution or reproduction is permitted which does not
comply with these terms.
Frontiers in Microbiology | Antimicrobials, Resistance and Chemotherapy February 2015 | Volume 6 | Article 78 | 10
